{
  "id": 15729395,
  "title": "Northrop Grumman earnings beat by $0.71, revenue was in line with estimates",
  "url": "https://urgent.news/2026/10/20/northrop-grumman-earnings-beat-by-0-71-revenue-was-in-line-with",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-10-20T10:10:26.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/earnings/northrop-grumman-earnings-beat-by-071-revenue-was-in-line-with-estimates-4959404"
  },
  "original_language": "en",
  "account": "Northrop Grumman reported a third quarter earnings per share (EPS) of $7.89, surpassing analysts' estimate by $0.71. The company's revenue for the quarter was $11.12 billion, matching the consensus estimate. Looking ahead, Northrop Grumman anticipates FY 2026 EPS between $29.35 and $29.75, slightly above the analyst consensus of $28.98. Similarly, the projected revenue for FY 2026 is between $43.75 billion and $44.25 billion, slightly higher than the analyst consensus of $44.05 billion. As of the latest data, Northrop Grumman's stock price closed at $510.65, marking a decrease of 4.28% over the past three months and a more significant 14.80% decline over the past year. In the last 90 days, the stock saw 16 positive EPS revisions and just one negative revision. Investing.com notes that Northrop Grumman's Financial Health score is \"good performance.\" For further insights, readers can explore the stock's past reactions to earnings and access the company's recent financials through Investing.com. To stay informed about upcoming earnings reports, the earnings calendar on Investing.com is recommended.",
  "summary": null,
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}